Fluorescence-Based Methods for Screening Writers and Readers of Histone Methyl Marks

Journal of Biomolecular Screening

Volumn 17, Issue 1, 2012, Pages 71-84

  Allali Hassani, Abdellah ^a   Wasney, Gregory A ^a   Siarheyeva, Alena ^a   Hajian, Taraneh ^a   Arrowsmith, Cheryl H ^a   Vedadi, Masoud ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSYLHOMOCYSTEINASE; EED PROTEIN, HUMAN; EHMT1 PROTEIN, HUMAN; EHMT2 PROTEIN, HUMAN; ENZYME INHIBITOR; HISTOCOMPATIBILITY ANTIGEN; HISTONE; HISTONE LYSINE METHYLTRANSFERASE; HISTONE METHYLTRANSFERASE; PEPTIDE; PRMT3 PROTEIN, HUMAN; PROTEIN ARGININE METHYLTRANSFERASE; REPRESSOR PROTEIN; SETD7 PROTEIN, HUMAN; SETD8 PROTEIN, HUMAN; SUV39H2 PROTEIN, HUMAN; WDR5 PROTEIN, HUMAN;

AMINO ACID SEQUENCE; ARTICLE; CHEMISTRY; DRUG ANTAGONISM; DRUG SCREENING; FLUORESCENCE; HIGH THROUGHPUT SCREENING; KINETICS; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; MOLECULAR LIBRARY;

ADENOSYLHOMOCYSTEINASE; AMINO ACID SEQUENCE; DRUG EVALUATION, PRECLINICAL; ENZYME INHIBITORS; FLUORESCENCE; HIGH-THROUGHPUT SCREENING ASSAYS; HISTOCOMPATIBILITY ANTIGENS; HISTONE-LYSINE N-METHYLTRANSFERASE; HISTONES; KINETICS; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN-ARGININE N-METHYLTRANSFERASES; REPRESSOR PROTEINS; SMALL MOLECULE LIBRARIES;

EID: 84861808843     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057111422256     Document Type: Article

References (74)

1. Kouzarides T. Chromatin Modifications and Their Function. Cell 2007, 128(4), 693–705.
2. O’Carroll D. Scherthan H. Peters A. H. Opravil S. Haynes A. R. Laible G. Rea S. Schmid M. Lebersorger A. Jerratsch M. Isolation and Characterization of Suv39h2, a Second Histone H3 Methyltransferase Gene That Displays Testis-Specific Expression. Mol. Cell. Biol. 2000, 20(24), 9423–9433.
3. Rea S. Eisenhaber F. O’Carroll D. Strahl B. D. Sun Z. W. Schmid M. Opravil S. Mechtler K. Ponting C. P. Allis C. D. Regulation of Chromatin Structure by Site-Specific Histone H3 Methyltransferases. Nature 2000, 406(6796), 593–599.
4. Dhayalan A. Kudithipudi S. Rathert P. Jeltsch A. Specificity Analysis-Based Identification of New Methylation Targets of the SET7/9 Protein Lysine Methyltransferase. Chem. Biol. 2011, 18(1), 111–120.
5. Huang J. Dorsey J. Chuikov S. Perez-Burgos L. Zhang X. Jenuwein T. Reinberg D. Berger S. L. G9a and Glp Methylate Lysine 373 in the Tumor Suppressor p53. J. Biol. Chem. 2010, 285(13), 9636–9641.
6. Liu X. Wang D. Zhao Y. Tu B. Zheng Z. Wang L. Wang H. Gu W. Roeder R. G. Zhu W. G. Methyltransferase SET7/9 Regulates p53 Activity by Interacting with Sirtuin 1 (Sirt1). Proc. Natl. Acad. Sci. U. S. A. 2011, 108(5), 1925–1930.
7. Pagans S. Kauder S. E. Kaehlcke K. Sakane N. Schroeder S. Dormeyer W. Trievel R. C. Verdin E. Schnolzer M. Ott M. The Cellular Lysine Methyltransferase SET7/9-KMT7 Binds HIV-1 TAR RNA, Monomethylates the Viral Transactivator Tat, and Enhances HIV Transcription. Cell Host Microbe 2010, 7(3), 234–244.
8. Singh V. Miranda T. B. Jiang W. Frankel A. Roemer M. E. Robb V. A. Gutmann D. H. Herschman H. R. Clarke S. Newsham I. F. Dal-1/4.1b Tumor Suppressor Interacts with Protein Arginine N-Methyltransferase 3 (PRMT3) and Inhibits Its Ability to Methylate Substrates In Vitro and In Vivo. Oncogene 2004, 23(47), 7761–7771.
9. Campagna-Slater V. Mok M. W. Nguyen K. T. Feher M. Najmanovich R. Schapira M. Structural Chemistry of the Histone Methyltransferases Cofactor Binding Site. J. Chem. Inf. Model 2011, 51(3), 612–623.
10. Bedford M. T. Richard S. Arginine Methylation an Emerging Regulator of Protein Function. Mol. Cell 2005, 18(3), 263–72.
11. Tang J. Gary J. D. Clarke S. Herschman H. R. PRMT 3, a Type I Protein Arginine N-Methyltransferase That Differs from PRMT1 in Its Oligomerization, Subcellular Localization, Substrate Specificity, and Regulation. J. Biol. Chem. 1998, 273(27), 16935–16945.
12. Bachand F. Silver P. A. PRMT3 Is a Ribosomal Protein Methyltransferase That Affects the Cellular Levels of Ribosomal Subunits. Embo. J. 2004, 23(13), 2641–2650.
13. Miyata S. Mori Y. Tohyama M. PRMT3 Is Essential for Dendritic Spine Maturation in Rat Hippocampal Neurons. Brain Res. 2010, 1352, 11–20.
14. Chang B. Chen Y. Zhao Y. Bruick R. K. JMJD6 Is a Histone Arginine Demethylase. Science 2007, 318(5849), 444–447.
15. Pal S. Sif S. Interplay between Chromatin Remodelers and Protein Arginine Methyltransferases. J. Cell Physiol. 2007, 213(2), 306–315.
16. Oda H. Hubner M. R. Beck D. B. Vermeulen M. Hurwitz J. Spector D. L. Reinberg D. Regulation of the Histone H4 Monomethylase PR-Set7 by CRL4(Cdt2)-Mediated PCNA-Dependent Degradation during DNA Damage. Mol. Cell 2010, 40(3), 364–376.
17. Oda H. Okamoto I. Murphy N. Chu J. Price S. M. Shen M. M. Torres-Padilla M. E. Heard E. Reinberg D. Monomethylation of Histone H4-Lysine 20 Is Involved in Chromosome Structure and Stability and Is Essential for Mouse Development. Mol. Cell Biol. 2009, 29(8), 2278–2295.
18. Shi X. Kachirskaia I. Yamaguchi H. West L. E. Wen H. Wang E. W. Dutta S. Appella E. Gozani O. Modulation of p53 Function by Set8-Mediated Methylation at Lysine 382. Mol. Cell 2007, 27(4), 636–646.
19. Nishioka K. Chuikov S. Sarma K. Erdjument-Bromage H. Allis C. D. Tempst P. Reinberg D. Set9, a Novel Histone H3 Methyltransferase That Facilitates Transcription by Precluding Histone Tail Modifications Required for Heterochromatin Formation. Genes Dev. 2002, 16(4), 479–489.
20. Esteve P. O. Chin H. G. Benner J. Feehery G. R. Samaranayake M. Horwitz G. A. Jacobsen S. E. Pradhan S. Regulation of DNMT1 Stability through SET7-Mediated Lysine Methylation in Mammalian Cells. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(13), 5076–5081.
21. Del Rizzo P. A. Couture J. F. Dirk L. M. Strunk B. S. Roiko M. S. Brunzelle J. S. Houtz R. L. Trievel R. C. Set7/9 Catalytic Mutants Reveal the Role of Active Site Water Molecules in Lysine Multiple Methylation. J. Biol. Chem. 2010, 285(41), 31849–31858.
22. Kurash J. K. Lei H. Shen Q. Marston W. L. Granda B. W. Fan H. Wall D. Li E. Gaudet F. Methylation of p53 by SET7/9 Mediates p53 Acetylation and Activity In Vivo. Mol. Cell 2008, 29(3), 392–400.
23. Munro S. Khaire N. Inche A. Carr S. La Thangue N. B. Lysine Methylation Regulates the PRB Tumour Suppressor Protein. Oncogene 2010, 29(16), 2357–2367.
24. Subramanian K. Jia D. Kapoor-Vazirani P. Powell D. R. Collins R. E. Sharma D. Peng J. Cheng X. Vertino P. M. Regulation of Estrogen Receptor Alpha by the SET7 Lysine Methyltransferase. Mol. Cell 2008, 30(3), 336–347.
25. Ea C. K. Baltimore D. Regulation of NF-kappaB Activity through Lysine Monomethylation of p65. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(45), 18972–18977.
26. Rathert P. Dhayalan A. Murakami M. Zhang X. Tamas R. Jurkowska R. Komatsu Y. Shinkai Y. Cheng X. Jeltsch A. Protein Lysine Methyltransferase G9a Acts on Non-Histone Targets. Nat. Chem. Biol. 2008, 4(6), 344–346.
27. Huang J. Berger S. L. The Emerging Field of Dynamic Lysine Methylation of Non-Histone Proteins. Curr. Opin. Genet. Dev. 2008, 18(2), 152–158.
28. Lee J. S. Kim Y. Kim I. S. Kim B. Choi H. J. Lee J. M. Shin H. J. Kim J. H. Kim J. Y. Seo S. B. Negative Regulation of Hypoxic Responses via Induced Reptin Methylation. Mol. Cell 2010, 39(1), 71–85.
29. Sampath S. C. Marazzi I. Yap K. L. Sampath S. C. Krutchinsky A. N. Mecklenbrauker I. Viale A. Rudensky E. Zhou M. M. Chait B. T. Methylation of a Histone Mimic within the Histone Methyltransferase G9a Regulates Protein Complex Assembly. Mol. Cell 2007, 27(4), 596–608.
30. Tachibana M. Ueda J. Fukuda M. Takeda N. Ohta T. Iwanari H. Sakihama T. Kodama T. Hamakubo T. Shinkai Y. Histone Methyltransferases G9a and GLP Form Heteromeric Complexes and Are Both Crucial for Methylation of Euchromatin at H3-K9. Genes Dev. 2005, 19(7), 815–826.
31. Tachibana M. Sugimoto K. Nozaki M. Ueda J. Ohta T. Ohki M. Fukuda M. Takeda N. Niida H. Kato H. G9a Histone Methyltransferase Plays a Dominant Role in Euchromatic Histone H3 Lysine 9 Methylation and Is Essential for Early Embryogenesis. Genes Dev. 2002, 16(14), 1779–1791.
32. Yokochi T. Poduch K. Ryba T. Lu J. Hiratani I. Tachibana M. Shinkai Y. Gilbert D. M. G9a Selectively Represses a Class of Late-Replicating Genes at the Nuclear Periphery. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(46), 19363–19368.
33. Wozniak R. J. Klimecki W. T. Lau S. S. Feinstein Y. Futscher B. W. 5-Aza-2′-Deoxycytidine-Mediated Reductions in G9a Histone Methyltransferase and Histone H3 K9 Di-Methylation Levels Are Linked to Tumor Suppressor Gene Reactivation. Oncogene 2007, 26(1), 77–90.
34. Chen M. W. Hua K. T. Kao H. J. Chi C. C. Wei L. H. Johansson G. Shiah S. G. Chen P. S. Jeng Y. M. Cheng T. Y. H3K9 Histone Methyltransferase G9a Promotes Lung Cancer Invasion and Metastasis by Silencing the Cell Adhesion Molecule Ep-CAM. Cancer Res. 2010, 70(20), 7830–7840.
35. Yoon K. A. Hwangbo B. Kim I. J. Park S. Kim H. S. Kee H. J. Lee J. E. Jang Y. K. Park J. G. Lee J. S. Novel Polymorphisms in the SUV39H2 Histone Methyltransferase and the Risk of Lung Cancer. Carcinogenesis 2006, 27(11), 2217–2222.
36. Kuzmichev A. Margueron R. Vaquero A. Preissner T. S. Scher M. Kirmizis A. Ouyang X. Brockdorff N. Abate-Shen C. Farnham P. Composition and Histone Substrates of Polycomb Repressive Group Complexes Change during cellular differentiation. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(6), 1859–1864.
37. Margueron R. Justin N. Ohno K. Sharpe M. L. Son J. Drury W. J. 3rd Voigt P. Martin S. R. Taylor W. R. De Marco V. Role of the Polycomb Protein EED in the Propagation of Repressive Histone Marks. Nature 2009, 461(7265), 762–767.
38. Southall S. M. Wong P. S. Odho Z. Roe S. M. Wilson J. R. Structural Basis for the Requirement of Additional Factors for MLL1 Set Domain Activity and Recognition of Epigenetic Marks. Mol. Cell 2009, 33(2), 181–191.
39. Odho Z. Southall S. M. Wilson J. R. Characterization of a Novel WDR5-Binding Site That Recruits RbBP5 through a Conserved Motif to Enhance Methylation of Histone H3 Lysine 4 by Mixed Lineage Leukemia Protein-1. J. Biol. Chem. 2010, 285(43), 32967–76.
40. Patel A. Vought V. E. Dharmarajan V. Cosgrove M. S. A Conserved Arginine-Containing Motif Crucial for the Assembly and Enzymatic Activity of the Mixed Lineage Leukemia Protein-1 Core Complex. J. Biol. Chem. 2008, 283(47), 32162–32175.
41. Dou Y. Milne T. A. Ruthenburg A. J. Lee S. Lee J. W. Verdine G. L. Allis C. D. Roeder R. G. Regulation of MLL1 H3K4 Methyltransferase Activity by Its Core Components. Nat. Struct. Mol. Biol. 2006, 13(8), 713–719.
42. Wysocka J. Swigut T. Milne T. A. Dou Y. Zhang X. Burlingame A. L. Roeder R. G. Brivanlou A. H. Allis C. D. WDR5 Associates with Histone H3 Methylated at K4 and Is Essential for H3 K4 Methylation and Vertebrate Development. Cell 2005, 121(6), 859–872.
43. Richon V. M. Johnston D. Sneeringer C. J. Jin L. Majer C. R. Elliston K. Fred Jerva L. Scott M. P. Copeland R. A. Chemogenetic Analysis of Human Protein Methyltransferases. Chem. Biol. Drug Des. 2011, 78(2), 199–210.
44. Kelly T. K. De Carvalho D. D. Jones P. A. Epigenetic Modifications as Therapeutic Targets. Nat. Biotechnol. 2010, 28(10), 1069–1078.
45. Vedadi M. Arrowsmith C. H. Allali-Hassani A. Senisterra G. Wasney G. A. Biophysical Characterization of Recombinant Proteins: A Key to Higher Structural Genomics Success. J. Struct. Biol. 2010, 172(1), 107–119.
46. Du Y. Moulick K. Rodina A. Aguirre J. Felts S. Dingledine R. Fu H. Chiosis G. High-Throughput Screening Fluorescence Polarization Assay for Tumor-Specific Hsp90. J. Biomol. Screen. 2007, 12(7), 915–924.
47. Kawamoto S. A. Thompson A. D. Coleska A. Nikolovska-Coleska Z. Yi H. Wang S. Analysis of the Interaction of BCL9 with Beta-Catenin and Development of Fluorescence Polarization and Surface Plasmon Resonance Binding Assays for This Interaction. Biochemistry 2009, 48(40), 9534–9541.
48. Reindl W. Graber M. Strebhardt K. Berg T. Development of High-Throughput Assays Based on Fluorescence Polarization for Inhibitors of the Polo-Box Domains of Polo-Like Kinases 2 and 3. Anal. Biochem. 2009, 395(2), 189–194.
49. Collazo E. Couture J. F. Bulfer S. Trievel R. C. A Coupled Fluorescent Assay for Histone Methyltransferases. Anal. Biochem. 2005, 342(1), 86–92.
50. Vedadi M. Barsyte-Lovejoy D. Liu F. Rival-Gervier S. Allali-Hassani A. Labrie V. Wigle T. J. DiMaggio P. A. Wasney G. A. Siarheyeva A. A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells. Nat. Chem. Biol. 2011, 7(8):566-74.
51. Liu F. Chen X. Allali-Hassani A. Quinn A. M. Wasney G. A. Dong A. Barsyte D. Kozieradzki I. Senisterra G. Chau I. Discovery of a 2,4-Diamino-7-Aminoalkoxyquinazoline as a Potent and Selective Inhibitor of Histone Lysine Methyltransferase G9a. J. Med. Chem. 2009, 52(24), 7950–7953.
52. Liu F. Chen X. Allali-Hassani A. Quinn A. M. Wigle T. J. Wasney G. A. Dong A. Senisterra G. Chau I. Siarheyeva A. Protein Lysine Methyltransferase G9a Inhibitors: Design, Synthesis, and Structure Activity Relationships of 2,4-Diamino-7-Aminoalkoxy-Quinazolines. J. Med. Chem. 2010, 53(15), 5844–5857.
53. Palmer N. A. Sattler S. E. Saathoff A. J. Sarath G. A Continuous, Quantitative Fluorescent Assay for Plant Caffeic Acid O-Methyltransferases. J. Agric. Food Chem. 2010, 58(9), 5220–5226.
54. Dorgan K. M. Wooderchak W. L. Wynn D. P. Karschner E. L. Alfaro J. F. Cui Y. Zhou Z. S. Hevel J. M. An Enzyme-Coupled Continuous Spectrophotometric Assay for S-Adenosylmethionine-Dependent Methyltransferases. Anal. Biochem. 2006, 350(2), 249–255.
55. Hendricks C. L. Ross J. R. Pichersky E. Noel J. P. Zhou Z. S. An Enzyme-Coupled Colorimetric Assay for S-Adenosylmethionine-Dependent Methyltransferases. Anal. Biochem. 2004, 326(1), 100–105.
56. Kubicek S. O’Sullivan R. J. August E. M. Hickey E. R. Zhang Q. Teodoro M. L. Rea S. Mechtler K. Kowalski J. A. Homon C. A. Reversal of H3K9me2 by a Small-Molecule Inhibitor for the G9a Histone Methyltransferase. Mol. Cell 2007, 25(3), 473–481.
57. Quinn A. M. Allali-Hassani A. Vedadi M. Simeonov A. A Chemiluminescence-Based Method for Identification of Histone Lysine Methyltransferase Inhibitors. Mol. Biosyst. 2010, 6(5), 782–788.
58. Cheng D. Yadav N. King R. W. Swanson M. S. Weinstein E. J. Bedford M. T. Small Molecule Regulators of Protein Arginine Methyltransferases. J. Biol. Chem. 2004, 279(23), 23892–23899.
59. Wigle T. J. Provencher L. M. Norris J. L. Jin J. Brown P. J. Frye S. V. Janzen W. P. Accessing Protein Methyltransferase and Demethylase Enzymology Using Microfluidic Capillary Electrophoresis. Chem. Biol. 2010, 17(7), 695–704.
60. Gowher H. Zhang X. Cheng X. Jeltsch A. Avidin Plate Assay System for Enzymatic Characterization of a Histone Lysine Methyltransferase. Anal. Biochem. 2005, 342(2), 287–291.
61. Dhayalan A. Dimitrova E. Rathert P. Jeltsch A. A Continuous Protein Methyltransferase (G9a) Assay for Enzyme Activity Measurement and Inhibitor Screening. J. Biomol. Screen. 2009, 14(9), 1129–1133.
62. Wu H. Min J. Lunin V. V. Antoshenko T. Dombrovski L. Zeng H. Allali-Hassani A. Campagna-Slater V. Vedadi M. Arrowsmith C. H. Structural Biology of Human H3K9 Methyltransferases. PLoS One 2010, 5(1), e8570.
63. Zhang J. H. Chung T. D. Oldenburg K. R. A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J. Biomol. Screen. 1999, 4(2), 67–73.
64. Nimura K. Ura K. Kaneda Y. Histone Methyltransferases: Regulation of Transcription and Contribution to Human Disease. J. Mol. Med. 2010, 88(12), 1213–1220.
65. Avdic V. Zhang P. Lanouette S. Groulx A. Tremblay V. Brunzelle J. Couture J. F. Structural and Biochemical Insights into MLL1 Core Complex Assembly. Structure 2011, 19(1), 101–108.
66. Crea F. Hurt E. M. Mathews L. A. Cabarcas S. M. Sun L. Marquez V. E. Danesi R. Farrar W. L. Pharmacologic Disruption of Polycomb Repressive Complex 2 Inhibits Tumorigenicity and Tumor Progression in Prostate Cancer. Mol. Cancer 2011, 10(1), 40.
67. Xu C. Bian C. Yang W. Galka M. Ouyang H. Chen C. Qiu W. Liu H. Jones A. E. MacKenzie F. Binding of Different Histone Marks Differentially Regulates the Activity and Specificity of Polycomb Repressive Complex 2 (PRC2). Proc. Natl. Acad. Sci. U. S. A. 2010, 107(45), 19266–19271.
68. Patnaik D. Chin H. G. Esteve P. O. Benner J. Jacobsen S. E. Pradhan S. Substrate Specificity and Kinetic Mechanism of Mammalian G9a Histone H3 Methyltransferase. J. Biol. Chem. 2004, 279(51), 53248–53258.
69. Xiao B. Jing C. Wilson J. R. Walker P. A. Vasisht N. Kelly G. Howell S. Taylor I. A. Blackburn G. M. Gamblin S. J. Structure and Catalytic Mechanism of the Human Histone Methyltransferase SET7/9. Nature 2003, 421(6923), 652–656.
70. Couture J. F. Collazo E. Hauk G. Trievel R. C. Structural Basis for the Methylation Site Specificity of SET7/9. Nat. Struct. Mol. Biol. 2006, 13(2), 140–146.
71. Trievel R. C. Beach B. M. Dirk L. M. Houtz R. L. Hurley JH. Structure and Catalytic Mechanism of a Set Domain Protein Methyltransferase. Cell 2002, 111(1), 91–103.
72. Dirk L. M. Flynn E. M. Dietzel K. Couture J. F. Trievel R. C. Houtz R. L. Kinetic Manifestation of Processivity during Multiple Methylations Catalyzed by Set Domain Protein Methyltransferases. Biochemistry 2007, 46(12), 3905–3915.
73. Couture J. F. Collazo E. Brunzelle J. S. Trievel R. C. Structural and Functional Analysis of SET8, a Histone H4 Lys-20 Methyltransferase. Genes Dev. 2005, 19(12), 1455–1465.
74. Pahlich S. Bschir K. Chiavi C. Belyanskaya L. Gehring H. Different Methylation Characteristics of Protein Arginine Methyltransferase 1 and 3 toward the Ewing Sarcoma Protein and a Peptide. Proteins 2005, 61(1), 164–175.